Status:
UNKNOWN
Measurement of Cerebral rSO2 Levels During Sleep in Children With Suspected Obstructive Sleep Apnea
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Obstructive Sleep Apnea
Pediatric Sleep Apnea
Eligibility:
All Genders
4-16 years
Phase:
EARLY_PHASE1
Brief Summary
The gold standard of obstructive sleep apnea (OSA) is (PSG)POLYSOMNOGRAPHY. During the examination, the patient is monitored by saturation, EEG and other measurements. Near infrared spectroscopy is a...
Detailed Description
a prospective cohort study study group - pediatric population referred to PSG in Dana Duek Hospital. After informed consent received from the parents, the parents will fulfill "Connors" (age 6 +) \& "...
Eligibility Criteria
Inclusion
- 4-16 y/o pediatric population referred for PSG in Dana Hospital
Exclusion
- down synd.
- craniofacial malformation
- PPD
Key Trial Info
Start Date :
September 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04321083
Start Date
September 11 2019
End Date
December 31 2022
Last Update
March 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana Duek pediatric hospital TASMC
Tel Aviv, Israel